Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - Northern Africa

Northern Africa

Revenue in the Diabetes Care Devices market market in Northern Africa is projected to reach US$236.50m in 2024.
Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 13.48%, which will result in a market volume of US$445.10m by 2029.
In a global context, the majority of revenue will be generated the United States, with a projection of US$11,710.00m in 2024.
In Northern Africa, the rising prevalence of diabetes is driving an increased demand for advanced diabetes care devices, particularly insulin delivery systems and continuous glucose monitors.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in Northern Africa is seeing moderate growth, influenced by factors like increasing prevalence of diabetes, rising health awareness, and the adoption of advanced technologies. However, affordability and access to care remain challenges impacting this growth.

Customer preferences: Consumers in Northern Africa are increasingly prioritizing personalized diabetes management solutions, reflecting a growing awareness of the condition and its implications. This shift is leading to heightened demand for smart glucose monitoring devices and mobile health applications that offer tailored insights. Additionally, the influence of social media is fostering community support and information sharing among diabetes patients, while urbanization and changing lifestyles are prompting a preference for more accessible and user-friendly diabetes care technologies.

Trends in the market: In Northern Africa, the Diabetes Care Devices Market is experiencing a significant shift towards digital health solutions, with an increasing adoption of smart glucose monitoring devices and mobile health applications. This trend reflects a heightened awareness of diabetes management, as consumers seek personalized insights to better control their condition. Furthermore, the rise of social media is enhancing community engagement, enabling patients to share experiences and support one another. As urbanization continues, the demand for user-friendly, accessible diabetes care technologies is likely to grow, presenting both opportunities and challenges for industry stakeholders in addressing diverse patient needs and preferences.

Local special circumstances: In Northern Africa, the Diabetes Care Devices Market is shaped by a unique blend of cultural attitudes towards health and varying levels of healthcare infrastructure. Traditional beliefs often influence dietary practices and lifestyle choices, impacting diabetes prevalence and management approaches. Additionally, regulatory challenges can hinder the swift approval of new technologies, while a lack of widespread insurance coverage limits access to advanced devices. However, the region’s youth demographic, increasingly tech-savvy, is driving demand for innovative solutions that integrate with mobile technology, fostering a burgeoning market for digital health tools.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Northern Africa is significantly influenced by macroeconomic factors such as national economic stability, healthcare funding, and global economic trends. Countries experiencing economic growth are more likely to invest in healthcare infrastructure, improving access to diabetes care technologies. Conversely, regions facing economic challenges may struggle to allocate sufficient resources for medical devices. Furthermore, fluctuations in global commodity prices can affect local healthcare budgets, impacting the affordability of advanced diabetes management tools. The rising prevalence of diabetes, coupled with increasing disposable incomes, is driving demand for innovative diabetes care devices, emphasizing the need for strategic investments in this sector.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.